ORIG3N
Financials
Estimates*
USD | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
Revenues | 3.4m | 3.4m | 3.4m | 3.4m | 3.4m |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$3.1m | Early VC | ||
$12.5m | Series A | ||
$20.0m | Early VC | ||
$14.4m | Series B | ||
N/A | $26.2m | Late VC | |
Total Funding | $76.2m |
Related Content
Recent News about ORIG3N
EditOrig3n operates in the genetic testing and wellness market, providing personalized DNA tests that offer insights into fitness, nutrition, and overall wellness. The company serves a diverse clientele, including individual consumers seeking to understand their genetic makeup and institutions requiring COVID-19 testing services. Orig3n's business model revolves around direct-to-consumer sales of DNA test kits and related wellness products, as well as B2B services for COVID-19 testing. Revenue is generated through the sale of these test kits and subscription-based access to personalized wellness plans. The company leverages a proprietary app to provide secure access to test results, enabling users to make informed decisions based on their unique genetic profiles.
Keywords: genetic testing, wellness, fitness, nutrition, personalized insights, DNA tests, COVID-19 testing, direct-to-consumer, B2B services, proprietary app.